Literature DB >> 19586665

Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation.

Ana Pocivavsek1, Irina Mikhailenko, Dudley K Strickland, G William Rebeck.   

Abstract

Apolipoprotein E (apoE)-induced activation of low-density lipoprotein receptor (LDL) family members reduces inflammatory responses by suppressing c-Jun N-terminal kinase (JNK) activation. We aimed to identify which specific receptor family member mediates the effect of apoE on inflammation in primary cultures of microglia. Low-density lipoprotein receptor-related protein 1 (LRP1)-deficient (LRP1-/-) microglia were derived from mice using tissue-specific loxP/Cre recombination. Using a peptide formed from the receptor-binding region of apoE (EP), we found that LRP1 mediates the effects of apoE on microglial inflammation. Microglial LRP1 was also essential for EP to suppress JNK activation induced by lipopolysaccharide.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19586665      PMCID: PMC2745483          DOI: 10.1016/j.jneuroim.2009.06.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  71 in total

1.  Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.

Authors:  T H Bugge; Q Xiao; K W Kombrinck; M J Flick; K Holmbäck; M J Danton; M C Colbert; D P Witte; K Fujikawa; E W Davie; J L Degen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production.

Authors:  D T Laskowitz; W D Matthew; E R Bennett; D Schmechel; M H Herbstreith; S Goel; M K McMillian
Journal:  Neuroreport       Date:  1998-03-09       Impact factor: 1.837

3.  Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures.

Authors:  N R Bhat; P Zhang; J C Lee; E L Hogan
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

4.  Apolipoprotein E suppresses glial cell secretion of TNF alpha.

Authors:  D T Laskowitz; S Goel; E R Bennett; W D Matthew
Journal:  J Neuroimmunol       Date:  1997-06       Impact factor: 3.478

5.  Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease.

Authors:  R H Christie; H Chung; G W Rebeck; D Strickland; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  1996-04       Impact factor: 3.685

6.  A cytoplasmic inhibitor of the JNK signal transduction pathway.

Authors:  M Dickens; J S Rogers; J Cavanagh; A Raitano; Z Xia; J R Halpern; M E Greenberg; C L Sawyers; R J Davis
Journal:  Science       Date:  1997-08-01       Impact factor: 47.728

7.  Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins.

Authors:  L M Dong; K H Weisgraber
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

8.  Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.

Authors:  D M Paresce; R N Ghosh; F R Maxfield
Journal:  Neuron       Date:  1996-09       Impact factor: 17.173

9.  Scavenging of Alzheimer's amyloid beta-protein by microglia in culture.

Authors:  M D Ard; G M Cole; J Wei; A P Mehrle; J D Fratkin
Journal:  J Neurosci Res       Date:  1996-01-15       Impact factor: 4.164

10.  APOE genotype-specific differences in the innate immune response.

Authors:  Michael P Vitek; Candice M Brown; Carol A Colton
Journal:  Neurobiol Aging       Date:  2007-12-21       Impact factor: 4.673

View more
  26 in total

1.  Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.

Authors:  Joshua B Owen; Rukhsana Sultana; Christopher D Aluise; Michelle A Erickson; Tulin O Price; Guojun Bu; William A Banks; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2010-10-07       Impact factor: 7.376

2.  LRP1 deficiency in microglia blocks neuro-inflammation in the spinal dorsal horn and neuropathic pain processing.

Authors:  Coralie Brifault; HyoJun Kwon; Wendy M Campana; Steven L Gonias
Journal:  Glia       Date:  2019-02-11       Impact factor: 7.452

3.  Apolipoprotein E Mimetic Peptide Increases Cerebral Glucose Uptake by Reducing Blood-Brain Barrier Disruption after Controlled Cortical Impact in Mice: An 18F-Fluorodeoxyglucose PET/CT Study.

Authors:  Xinghu Qin; Hong You; Fang Cao; Yue Wu; Jianhua Peng; Jinwei Pang; Hong Xu; Yue Chen; Ligang Chen; Michael P Vitek; Fengqiao Li; Xiaochuan Sun; Yong Jiang
Journal:  J Neurotrauma       Date:  2016-09-27       Impact factor: 5.269

Review 4.  Therapeutic Development of Apolipoprotein E Mimetics for Acute Brain Injury: Augmenting Endogenous Responses to Reduce Secondary Injury.

Authors:  Michael L James; Jordan M Komisarow; Haichen Wang; Daniel T Laskowitz
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

5.  APOE Genotype Alters Immunoglobulin Subtypes in Knock-In Mice.

Authors:  Ye Zhou; Wenjuan Zhao; Nour Al-Muhtasib; G William Rebeck
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 6.  The role of APOE on lipid homeostasis and inflammation in normal brains.

Authors:  G William Rebeck
Journal:  J Lipid Res       Date:  2017-03-02       Impact factor: 5.922

7.  APOE genotype alters glial activation and loss of synaptic markers in mice.

Authors:  Yuangui Zhu; Evelyn Nwabuisi-Heath; Sonya B Dumanis; Leon M Tai; Chunjiang Yu; G William Rebeck; Mary Jo LaDu
Journal:  Glia       Date:  2012-01-06       Impact factor: 7.452

8.  LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways.

Authors:  Benoit Langlois; Gwenn Perrot; Christophe Schneider; Patrick Henriet; Hervé Emonard; Laurent Martiny; Stéphane Dedieu
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

Review 9.  Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

Authors:  Mariana F Uchoa; V Alexandra Moser; Christian J Pike
Journal:  Front Neuroendocrinol       Date:  2016-09-17       Impact factor: 8.606

Review 10.  An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer's Disease.

Authors:  Blaise W Menta; Russell H Swerdlow
Journal:  Neurochem Res       Date:  2018-08-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.